Hesham Elsabah
Overview
Explore the profile of Hesham Elsabah including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
52
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Marashi M, Al Farsi K, Al Hateeti H, Alhuraiji A, Elsabah H, Cherif H, et al.
Clin Hematol Int
. 2025 Feb;
7(1):14-28.
PMID: 39944235
Treatment options for newly diagnosed multiple myeloma (NDMM) have expanded dramatically over the last two decades, resulting in remarkable improvements in response rates and median survival times. In eligible patients,...
2.
A ElKourashy S, Soliman D, El Omri A, Y Taha R, Elsabah H, Alashi H, et al.
Hematology
. 2024 Dec;
29(1):2392467.
PMID: 39665684
Background: In MENA region, there is a lack of evidence on Primary Myelofibrosis (PMF), leading to its underrepresentation in medical literature. This study marks the first comprehensive report on PMF...
3.
Elsabah H, Ghasoub R, El Omri H, Benkhadra M, Cherif H, Y Taha R
Front Oncol
. 2024 Jul;
14:1390747.
PMID: 39050574
Introduction: Venetoclax is a BCL-2 inhibitor with proven efficacy in patients with multiple myeloma (MM) and translocation t(11;14). However, its role in plasma cell leukemia (PCL) remains unclear. Herein, we...
4.
Elsabah H, Ghasoub R, Soliman D, Ibrahim F, Aldapt M, Y Taha R, et al.
Cancer Rep (Hoboken)
. 2024 Jul;
7(7):e2106.
PMID: 38967112
Background: Plasmacytoma of the skull base is a rare manifestation of plasma cell neoplasm with only a few cases documented in literature involving young adults. Plasmacytoma can be an isolated...
5.
Ghasoub R, Elazzazy S, Benkhadra M, Kassem N, Cherif H, Gaziev J, et al.
J Am Pharm Assoc (2003)
. 2024 Jun;
64(5):102141.
PMID: 38844021
Background: Multiple myeloma (MM) is a chronic and incurable hematologic malignancy that is prevalent among the elderly. Interprofessional patient care showed superiority over physician-only care in multiple settings, including MM....
6.
Elsabah H, El Omri H, Habas E, Y Taha R, A ElKourashy S, Ibrahim F, et al.
Front Med (Lausanne)
. 2024 Mar;
11:1338552.
PMID: 38444413
Background: Multiple myeloma (MM) is one of the most common hematological malignancies globally, and it is projected to increase in the coming years. It occurs more frequently in males and...
7.
Abdulgayom M, Soliman D, Helmy A, Haroon A, Telfah H, Ghasoub R, et al.
Case Rep Oncol
. 2024 Feb;
17(1):291-297.
PMID: 38371169
Introduction: Multiple myeloma (MM) is a clonal neoplasm of plasma cells that may manifest as an extramedullary disease in rare cases. Case Report: In this case report, we present the...
8.
El Omri H, Padmanabhan R, Y Taha R, Kassem N, Elsabah H, Ellahie A, et al.
J Infect Public Health
. 2023 Nov;
17(1):152-162.
PMID: 38029491
Background: The use of ill-suited antibiotics is a significant risk factor behind the increase in the mortality, morbidity, and economic burden for patients who are under treatment for hematological malignancy...
9.
Kassem N, Alshurafa A, Elsabah H, El Omri H
Clin Case Rep
. 2023 Nov;
11(11):e8223.
PMID: 38028081
Erythema nodosum (EN) is a type of panniculitis occurring due to various conditions. It can be associated with certain malignancies or manifest as a side effect of drugs. This article...
10.
Ghasoub R, Benkhadra M, Kassem N, Alshurafa A, Elsabah H
J Oncol Pharm Pract
. 2023 Jul;
29(8):2041-2044.
PMID: 37489075
Introduction: Carfilzomib is a second-generation selective proteasome inhibitor that is commonly used in the treatment of relapsed or refractory multiple myeloma. Carfilzomib is associated with respiratory side effects, such as...